Cargando…

Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer

The molecular underpinnings of acquired resistance to carboplatin are poorly understood and often inconsistent between in vitro modeling studies. After sequential treatment cycles, multiple isogenic clones reached similar levels of resistance, but significant transcriptional heterogeneity. Gene-expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenzel, Alexander T., Champa, Devora, Venkatesh, Hrishi, Sun, Si, Tsai, Cheng-Yu, Mesirov, Jill P., Bui, Jack D., Howell, Stephen B., Harismendy, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206019/
https://www.ncbi.nlm.nih.gov/pubmed/35715421
http://dx.doi.org/10.1038/s41540-022-00230-z
_version_ 1784729253267374080
author Wenzel, Alexander T.
Champa, Devora
Venkatesh, Hrishi
Sun, Si
Tsai, Cheng-Yu
Mesirov, Jill P.
Bui, Jack D.
Howell, Stephen B.
Harismendy, Olivier
author_facet Wenzel, Alexander T.
Champa, Devora
Venkatesh, Hrishi
Sun, Si
Tsai, Cheng-Yu
Mesirov, Jill P.
Bui, Jack D.
Howell, Stephen B.
Harismendy, Olivier
author_sort Wenzel, Alexander T.
collection PubMed
description The molecular underpinnings of acquired resistance to carboplatin are poorly understood and often inconsistent between in vitro modeling studies. After sequential treatment cycles, multiple isogenic clones reached similar levels of resistance, but significant transcriptional heterogeneity. Gene-expression based virtual synchronization of 26,772 single cells from 2 treatment steps and 4 resistant clones was used to evaluate the activity of Hallmark gene sets in proliferative (P) and quiescent (Q) phases. Two behaviors were associated with resistance: (1) broad repression in the P phase observed in all clones in early resistant steps and (2) prevalent induction in Q phase observed in the late treatment step of one clone. Furthermore, the induction of IFNα response in P phase or Wnt-signaling in Q phase were observed in distinct resistant clones. These observations suggest a model of resistance hysteresis, where functional alterations of the P and Q phase states affect the dynamics of the successive transitions between drug exposure and recovery, and prompts for a precise monitoring of single-cell states to develop more effective schedules for, or combination of, chemotherapy treatments.
format Online
Article
Text
id pubmed-9206019
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92060192022-06-19 Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer Wenzel, Alexander T. Champa, Devora Venkatesh, Hrishi Sun, Si Tsai, Cheng-Yu Mesirov, Jill P. Bui, Jack D. Howell, Stephen B. Harismendy, Olivier NPJ Syst Biol Appl Article The molecular underpinnings of acquired resistance to carboplatin are poorly understood and often inconsistent between in vitro modeling studies. After sequential treatment cycles, multiple isogenic clones reached similar levels of resistance, but significant transcriptional heterogeneity. Gene-expression based virtual synchronization of 26,772 single cells from 2 treatment steps and 4 resistant clones was used to evaluate the activity of Hallmark gene sets in proliferative (P) and quiescent (Q) phases. Two behaviors were associated with resistance: (1) broad repression in the P phase observed in all clones in early resistant steps and (2) prevalent induction in Q phase observed in the late treatment step of one clone. Furthermore, the induction of IFNα response in P phase or Wnt-signaling in Q phase were observed in distinct resistant clones. These observations suggest a model of resistance hysteresis, where functional alterations of the P and Q phase states affect the dynamics of the successive transitions between drug exposure and recovery, and prompts for a precise monitoring of single-cell states to develop more effective schedules for, or combination of, chemotherapy treatments. Nature Publishing Group UK 2022-06-17 /pmc/articles/PMC9206019/ /pubmed/35715421 http://dx.doi.org/10.1038/s41540-022-00230-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Wenzel, Alexander T.
Champa, Devora
Venkatesh, Hrishi
Sun, Si
Tsai, Cheng-Yu
Mesirov, Jill P.
Bui, Jack D.
Howell, Stephen B.
Harismendy, Olivier
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
title Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
title_full Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
title_fullStr Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
title_full_unstemmed Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
title_short Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
title_sort single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206019/
https://www.ncbi.nlm.nih.gov/pubmed/35715421
http://dx.doi.org/10.1038/s41540-022-00230-z
work_keys_str_mv AT wenzelalexandert singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer
AT champadevora singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer
AT venkateshhrishi singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer
AT sunsi singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer
AT tsaichengyu singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer
AT mesirovjillp singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer
AT buijackd singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer
AT howellstephenb singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer
AT harismendyolivier singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer